Skip to main content
. 2024 Apr 20;16(8):1228. doi: 10.3390/nu16081228

Figure 5.

Figure 5

Effect of the intervention on participants with migraine or atopic dermatitis. (A) Effect of gluten (n = 12) and placebo (n = 12) on Migraine Disability Assessment (MIDAS) among participants with migraine. (B) Effect of gluten (n = 6) and placebo (n = 14) on the Three-Item Severity (TIS) score among participants with atopic dermatitis. ∆ = Final − Basal. * p < 0.05.